Stay updated with breaking news from Obstructive Sleep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month. The updated data indicate the FLOSAT study is on track to achieve all endpoints.
The Rose of Tralee 2023 is upon us - get to know the Roses from the US and Canada!
28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...
Public Announcement Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea ...
Public Announcement Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of...